|
Back to Home » May 2021 News » Diadem Presents New Data at AAIC® Symposium Showing Its Blood-Based Biomarker Test Accurately Predicts Progression to Alzheimer's Disease 7 Years Before Symptoms Occur |
Diadem Presents New Data at AAIC® Symposium Showing Its Blood-Based Biomarker Test Accurately Predicts Progression to Alzheimer's Disease 7 Years Before Symptoms Occur |
May 13, 2021
MILAN, Italy, May 13, 2021 /PRNewswire/ -- Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced new data showing that its AlzoSure® prognostic biomarker test can accurately predict progression to Alzheimer's...
Source URL: https://www.prnewswire.com:443/news-releases/diadem-presents-new-data-at-aaic-symposium-showing-its-blood-based-biomarker-test-accurately-predicts-progression-to-alzheimers-disease-7-years-before-symptoms-occur-301290455.html
|
|
|
|
